India

Pills in Peril: Paracetamol, Pan D, and More Fail Drug Quality Test—Health Risks Raised!

The Central Drugs Standards Control Organisation (CDSCO) has flagged over 50 medicines, including paracetamol, Pan D, and calcium supplements, as “not of standard quality” in its latest monthly quality check report, sparking concerns about their safety.

In its August 2024 report, the central drug regulator categorized several drugs, such as vitamin D and calcium supplements, high blood pressure medications, and certain anti-diabetes pills, under the “Not of Standard Quality (NSQ Alert)” category. These alerts result from random monthly sampling conducted by state drug officials.

The list of drugs failing the quality test includes vitamin C and D3 tablets, Shelcal, vitamin B complex, vitamin C softgels, anti-acid Pan-D, paracetamol tablets (IP 500 mg), the anti-diabetic drug Glimepiride, and the high blood pressure medication Telmisartan.

These medications were produced by various companies, including Hetero Drugs, Alkem Laboratories, Hindustan Antibiotics Limited (HAL), Karnataka Antibiotics & Pharmaceuticals Ltd, Pure & Cure Healthcare, and Meg Lifesciences, among others.

Metronidazole, a commonly used treatment for stomach infections manufactured by HAL, also failed the quality test. Likewise, Shelcal, a widely used calcium and vitamin D3 supplement, has been flagged in the NSQ Alert category.

A drug-testing lab in Kolkata classified antibiotics like Clavam 625 and Pan D as spurious. Cepodem XP 50 Dry Suspension, a popular infection medication for children, was also flagged by CDSCO for not meeting quality standards.

The central drug regulator issued two lists: one featuring 48 drugs that failed quality tests and another listing 5 drugs in the NSQ Alert category, along with responses from their manufacturers.

One response from Pulmosil’s manufacturer stated, “The actual manufacturer (as per label claim) has informed that the impugned batch of the product has not been manufactured by them and that it is a spurious drug. The product is purported to be spurious, however, the same is subjected to outcome of investigation.”

Earlier in August, CDSCO banned over 156 fixed-dose drug combinations nationwide, citing potential risks to human health.

Swimmi Srivastava

**Swimmi Shrivastava** Swimmi Shrivastava is a seasoned journalist with extensive experience across diverse beats, including politics, elections, civic affairs, water resources, power sector, and more. Currently serving as a Senior Sub-Editor at *The Daily Guardian*, she is renowned for her insightful news reports, engaging blogs, and thought-provoking articles. An alumnus of Delhi University, Swimmi further honed her journalistic expertise by earning a diploma in Print Media Journalism from Bharatiya Vidya Bhavan. With a sharp eye for detail and a commitment to impactful storytelling.

Recent Posts

Five Lingering Questions After Actor Saif Ali Khan’s Stabbing Incident in Bandra

Saif Ali Khan stabbed in Bandra home; attacker escapes. Police investigate security breaches and insider…

6 minutes ago

‘Terrible Entrepreneur’: Gaurav Taneja ‘Flying Beast’ Rs 1 Crore Pitch Gets Rejected On Shark Tank | WATCH

YouTuber Gaurav Taneja's BeastLife pitch on Shark Tank India faced rejection as Sharks questioned his…

15 minutes ago

US Rolls Out New H-1B Visa Rules to Boost Fairness and Efficiency

The U.S. has implemented new H-1B visa rules to improve fairness, reduce fraud, and streamline…

21 minutes ago

‘Someone, Please Explain The Maths!’: Zepto’s Billing Blunder, Reddit Reacts

A Reddit user called out Zepto's confusing billing breakdown, sparking online debate. Users mocked the…

27 minutes ago

Hostage Deal Signed, But Gaza Ceasefire Faces Internal Divisions

Prime Minister Netanyahu announced a deal to release hostages and pause the fighting in Gaza,…

44 minutes ago

Jessica Alba Reflects on 16 Year Marriage with Cash Warren in Emotional Post

Jessica Alba and Cash Warren are separating after 16 years of marriage, focusing on individual…

1 hour ago